|Articles|March 15, 2004
FDA approves generic equivalent to ophthalmic ointment
The FDA has approved Akorn Inc.'s abbreviated new drug application for neomycin and polymyxin B sulfates, and bacitracin zinc ophthalmic ointment USP, a generic therapeutic equivalent to Monarch Pharmaceuticals' Neosporin ophthalmic ointment.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA accepts resubmitted ONS-5010 BLA from Outlook Therapeutics
2
Post-hoc AREDS2 analysis highlights distinct mechanisms driving GA progression
3
Five-year GALE study data announced
4
When policy meets parenthood: Examining residency leave in ophthalmology
5















































.png)


